Antibodies affecting ion channel function in acquired neuromyotonia, in seropositive and seronegative myasthenia gravis, and in antibody-mediated arthrogryposis multiplex congenita

Annals of the New York Academy of Sciences

Volumn 841, Issue , 1998, Pages 482-496

  Vincent, Angela ^a   Jacobson, Leslie ^a   Plested, Paul ^a   Polizzi, Agata ^a   Tang, Teresa ^a   Riemersma, Sietske ^a   Newland, Claire ^a   Ghorazian, Sara ^a   Farrar, Jeremy ^a   Maclennan, Cal ^a   Willcox, Nicholas ^a   Beeson, David ^a   Newsom Davis, John ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CALCIUM CHANNEL; CHOLINERGIC RECEPTOR ANTIBODY; ION CHANNEL; POTASSIUM CHANNEL;

ACQUIRED NEUROMYOTONIA; ANTIBODY SPECIFICITY; ARTHROGRYPOSIS; CONFERENCE PAPER; EATON LAMBERT SYNDROME; HUMAN; MYASTHENIA GRAVIS; NEUROMUSCULAR DISEASE; NEUROMUSCULAR TRANSMISSION;

EID: 0031903622     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb10968.x     Document Type: Conference Paper

References (38)

1. NEWSOM-DAVIS, J. & K. R. MILLS. 1993. Immunological associations of acquired neuromyotonia (Isaacs' syndrome): report of five cases and literature review. Brain 116: 453-469.
2. SINHA, S., J. NEWSOM-DAVIS, K. MILLS et al. 1991. Autoimmune aetiology for acquired neuromyotonia (Isaacs' syndrome). Lancet 338: 75-77.
3. BADY, B., G. CHAUPLANNAZ, C. VIAL et al. 1991. Autoimmune aetiology for acquired neuromyotonia. Lancet 338: 1330.
4. WINTZEN, A. R., J. G. VAN DIJK & A. BRAND. 1994. Neuromyotonia with early response to plasmapheresis associated with proximal action myoclonus with late response to plasmapheresis. Muscle Nerve 17(suppl. 1): S221.
5. + channels of peripheral nerves. Ann. Neurol. 38: 714-722.
6. + channels are implicated in neuromyotonia (Isaacs' syndrome). Ann. Neurol. 41: 238-246.
7. HALBACH, M., V. HOMBERG & H-J. FREUND. 1987. Neuromuscular, autonomic, and central cholinergic hyperactivity associated with thymoma and acetylcholine receptor-binding antibody. J. Neurol. 234: 433-436.
8. VINCENT, A., P. J. WHITING, M. SCHLUEP et al. 1987. Antibody heterogeneity and specificity in myasthenia gravis. Ann. N.Y. Acad. Sci. 505: 106-120.
9. TZARTOS, S. J., T. BARKAS, M. T. CUNG et al. 1991. The main immunogenic region of the acetylcholine receptor: structure and role in myasthenia gravis. Autoimmunity 8: 259-270.
10. VINCENT, A. & J. NEWSOM-DAVIS. 1982. Acetylcholine receptor antibody characteristics in myasthenia gravis. 1. Patients with generalized myasthenia or disease restricted to ocular muscles. Clin. Exp. Immunol. 49: 257-265.
11. BEESON, D., M. AMAR, I. BERMUDEZ et al. 1996. Stable high level expression of the adult subtype of human muscle acetylcholine receptor in the TE671 cell line following transfection with cDNA encoding the e subunit. Neurosci. Lett. 207: 57-60.
12. GEUDER, K. I., A. MARX, V WITZEMANN et al. 1992. Genomic organization and lack of transcription of the nicotinic acetylcholine receptor subunit genes in myasthenia gravis-associated thymoma. Lab. Invest. 66: 452-458.
13. KAMINSKI, H. J., R. A. FENSTERMAKER, F. W. ABDUL KARIM et al. 1993. Acetylcholine receptor subunit gene expression in thymic tissue. Muscle Nerve 16: 1332-1337.
14. HORTON, R. M., A. A. MANFREDI & B. M. CONTI-TRONCONI. 1993. The "embryonic" gamma subunit of the nicotinic acetylcholine receptor is expressed in adult extraocular muscle. Neurology 43(5): 983-985.
15. KAMINSKI, H., L. KUSNER & C. BLOCK. 1996. Expression of acetylcholine receptor isoforms at extraocular endplates. Invest. Ophthalmol. Visual Sci. 321: 406-411.
16. MACLENNAN, C., D. BEESON, A-M. BUIJS et al. 1997. Acetylcholine receptor expression in human extraocular muscles and their susceptibility to myasthenia gravis. Ann. Neurol. 41: 423-431.
17. KAMINSKI, H. J. & U. L. RUFF. 1997. Ocular muscle involvement by myasthenia gravis. Editorial. Ann. Neurol. 41: 419-420.
18. BEESON, D., L. JACOBSON, J. NEWSOM-DAVIS et al. 1996. A transfected human muscle cell line expressing the adult subtype of the human muscle acetylcholine receptor for diagnostic assays in myasthenia gravis. Neurology 47: 1552-1555.
19. VINCENT, A. 1980. Immunology of acetylcholine receptors in relation to myasthenia gravis. Physiol. Rev. 60: 756-824.
20. WHITING, P. J., A. VINCENT & J. NEWSOM-DAVIS. 1986. Myasthenia gravis: monoclonal antihuman acetylcholine receptor antibodies used to analyze antibody specificities and responses to treatment. Neurology 36: 612-617.
21. TZARTOS, S. J. & J. L. LINDSTROM. 1980. Monoclonal antibodies to probe acetylcholine receptor structure: localization of the main immunogenic region and detection of similarities between subunits. Proc. Natl. Acad. Sci. U.S.A. 77: 755-759.
22. HEIDENREICH, F., A. VINCENT, A. ROBERTS et al. 1988. Epitopes on human acetylcholine receptor defined by monoclonal antibodies and myasthenia gravis sera. Autoimmunity 1: 285-297.
23. FARRAR, J., S. PORTOLANO, N. WILLCOX et al. 1997. Diverse Fabs specific for acetylcholine receptor epitopes from a myasthenia gravis thymus combinatorial library. Int. Immunol. In press.
24. GRAUS, Y. F., M. H. DE BAETS, P. W. H. PARREN et al. 1997. Human anti-nicotinic acetylcholine receptor recombinant Fab fragments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predominant specificities in serum and block the action of pathogenic serum antibodies. J. Immunol. 158: 1919-1929.
25. DRACHMAN, D. B. & A. J. COULOMBRE. 1961. Experimental clubfoot and arthrogryposis multiplex congenita. Lancet ii: 523.
26. VERNET DER GARABEDIAN, B., M. LACOKOVA, B. EYMARD et al. 1994. Association of neonatal myasthenia gravis with antibodies against the fetal acetylcholine receptor. J. Clin. Invest. 94: 555-559.
27. HALL, J. G. 1990. Arthrogryposes (multiple congenital contractures). In Principles and Practice of Medical Genetics. Churchill Livingstone. New York.
28. VINCENT, A., C. NEWLAND, L. BRUETON et al. 1995. Arthrogryposis multiplex congenita with maternal autoantibodies specific for a fetal antigen. Lancet 346: 24-25.
29. BARNES, P., D. KANABAR, L. BRUETON et al. 1994. Recurrent congenital arthrogryposis leading to a diagnosis of myasthenia gravis in an initially asymptomatic mother. Neuromusc. Dis. 5: 59-65.
30. RIEMERSMA, S., A. VINCENT, D. BEESON et al. 1996. Association of arthrogryposis multiplex congenita with maternal antibodies inhibiting fetal acetylcholine receptor function. J. Clin. Invest. 98: 2358-2363.
31. SANDERS, D. B., I. ANDREWS, J. F. HOWARD et al. 1997. Seronegative myasthenia gravis. Neurology 48(suppl. 5): S40-S45.
32. VINCENT, A., Z. LI, A. HART et al. 1993. Seronegative myasthenia gravis: evidence for plasma factor(s) interfering with acetylcholine receptor function. Ann. N.Y. Acad. Sci. 681: 529-538.
33. MOSSMAN, S., A. VINCENT & J. NEWSOM-DAVIS. 1986. Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity. Lancet i: 116-119.
34. BURGES, J., D. W. WRAY, S. PIZZIGHELLA et al. 1990. A myasthenia gravis plasma immunoglobulin reduces miniature endplate potentials at human endplates in vitro. Muscle Nerve 13: 407-413.
35. YAMAMOTO, T., A. VINCENT, T. A. CIULLA et al. 1991. Seronegative myasthenia gravis: a plasma factor inhibiting agonist-induced acetylcholine receptor function copurifies with IgM. Ann. Neurol. 30: 550-557.
36. BARRETT-JOLLEY, R., N. BYRNE, A. VINCENT et al. 1994. Seronegative myasthenia gravis plasmas reduce acetylcholine-induced currents in TE671 cells. Pflügers Arch. 428: 492-498.
37. LI, Z., N. FORESTER & A. VINCENT. Modulation of acetylcholine receptor function in TE671 (rhabdomyosarcoma) cells by non-AChR ligands; a role in seronegative myasthenia gravis? J. Neuroimmunol. 64: 179-184.
38. HUGANIR, R. L. & K. MILES. 1989. Protein phosphorylation of nicotinic acetylcholine receptors. Crit. Rev. Biochem. 24: 183-215.